Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{184326,
        author = {Shobhit Sharma and Dr. Rakesh Kumar and Dr. Pooja Sharma and Dr. khushboo Lavania},
        title = {QUALITY BY DESIGN: AN OVERVIEW},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {4},
        pages = {893-898},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=184326},
        abstract = {A new method for developing products called quality by design (QbD) has significant business advantages across the course of the product life cycle. In the modern pharmaceutical quality control procedure, QbD has taken on a crucial role. The corner stone’s of QbD are Q8 (pharmaceutical development), Q9 (quality risk management), and Q10 (quality systems) of the ICH standards. To design and develop the formulation and process, QbD defines the risk assessment, life cycle management, critical quality characteristics (CQA), and quality target product profile (QTPP). In order to guarantee the seamless production and high calibre of pharmaceuticals, this study aims to explain how QbD can be applied.},
        keywords = {QbD, ICH guidelines, Pharmaceutical, Quality control, Manufacturing, Design space, QTPP, CQAs.},
        month = {September},
        }